Active
SME

Invicta Diagnostic Ltd

Invicta Diagnostic Ltd IPO Details

Listing Date

08 Dec 2025

Bid Price

₹80 - ₹85

Lot Size

1600 Shares

Minimum Investment

₹2,72,000 / 2 Lots

Issue Size

₹28.12 Cr

Schedule

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

1st Dec

tick

Offer End Date

3rd Dec

tick

Allotment Date

4th Dec

tick

Refund Initiation

5th Dec

tick

Demat Transfer

5th Dec

tick

Listing Date

8th Dec

About Invicta Diagnostic Ltd IPO

Incorporated in January 2021, Invicta Diagnostic Limited operates in the radiology and pathology space, offering its services under the brand “PC Diagnostics.” The company functions through a network of diagnostic centres and a central laboratory spread across the Mumbai Metropolitan Region. Its hub-and-spoke structure includes a main hub in Thane West that provides a wide range of pathology tests and advanced radiology services such as PET CT and MRI. Additional hubs in Bhayandar, Byculla, and Marol support specialised diagnostic needs, while spoke centres in Lower Parel, Sewri, and Kalwa focus on basic imaging and sample collection. This structure allows the company to extend its services across different parts of the region.
 

Invicta Diagnostic Limited offers a broad mix of routine and specialised pathology tests along with basic and advanced radiology procedures. Routine tests include CBC, thyroid panels, lipid profiles, and liver and kidney function assessments, while specialised services cover molecular diagnostics, immunoassays, infectious disease markers, cancer indicators, and genetic testing. The company also maintains a sample collection network supported by trained phlebotomists and authorised partners, enabling patients to provide samples either from home or through spoke centres. As of 31 October 2025, the organisation employed 157 permanent staff members and continued operating seven diagnostic centres and one centralised laboratory across the Mumbai Metropolitan Region.

Invicta Diagnostic Ltd Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 90.52% 66.7%
Public Group 9.48% 33.3%

Invicta Diagnostic Ltd IPO Reservation

QIB Shares Offered 6,28,672 (19%)
NII (HNI) Shares Offered 4,71,504 (14.25%)
Retail Shares Offered 11,00,176 (33.25%)
Anchor Investor Shares Offered 9,43,008 (28.5%)
Total Shares Offered 33,08,800
Total Shares With Anchor Investor 33,08,800

Invicta Diagnostic Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 2 3,200 ₹2,72,000
Retail (Max) 2 3,200 ₹2,72,000
S HNI (Min) 3 4,800 ₹4,08,000
S HNI (Max) 7 11,200 ₹9,52,000
B HNI (MIN) 8 12,800 ₹10,88,000

Invicta Diagnostic Ltd IPO Anchor Portion Size

Bid Date March 28, 2025
Shares Offered 7,98,400
Anchor Investment Details 6.7864

Invicta Diagnostic Ltd IPO registrar

Bigshare Services Pvt Ltd
Phone Number 022 - 6263 8200
Email Id ipo@bigshareonline.com
Website www.bigshareonline.com

Invicta Diagnostic Ltd IPO Lead Manager

1. Socradamus Capital Pvt Ltd

Invicta Diagnostic Ltd Financial Information

March 31, 2025 March 31, 2024 March 31,
Net Worth ₹16.83 Cr ₹12.18 Cr ₹ Cr
Reserves and Surplus ₹8.41 Cr ₹12.05 Cr ₹ Cr
Total Borrowing ₹1.68 Cr ₹1.87 Cr ₹ Cr

Invicta Diagnostic Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid Subscription (Times)
Qualified Institutional Buyers (QIBs) 6,28,672 18,75,200 2.9828
Non Institutional Investors (NIIs) 6,36,944 39,40,800 6.187
Retail Individual Investors (RIIs) 11,00,176 43,61,600 3.9645
Total 25,10,400 1,01,77,600 4.0542

Strength of Invicta Diagnostic Ltd

  • Expanding presence in Mumbai Metropolitan Region ("MMR") specifically in radiology sector.
  • Diagnostics provider that offers one-stop solution at affordable price.
  • Technical capability and technology with IT infrastructure.
  • Dedicated management team with significant industry experience.
  • Implementation of Hub and Spoke Model.

Risks Involved

  • Its business and prospects may be adversely affected if the company is unable to maintain and grow its brand name and brand image.
  • Any interruptions at its flagship centre and other diagnostic centres may affect the company ability to process diagnostic tests, which in turn may adversely affect its business, results of operations and financial condition.
  • Concentrated emphasis on radiology services also exposes it to substantial risks that could adversely impact its operations, financial performance, and long-term growth prospects.
  • The company operations are concentrated in Mumbai Metropolitan Region ("MMR"), and any loss of business in such region could have an adverse effect on its business, results of operations and financial condition.
  • Its ability to remain competitive may be adversely affected by technological advancements, innovations in diagnostic testing and its ability to access such technology.
  • The company operates in a highly competitive business environment, and its inability to compete effectively could have an adverse effect on the company business, results of operations and financial condition.
  • Failures to establish and comply with appropriate quality standards when performing imaging, testing and diagnostics services could result in litigation and liability for it and could materially and adversely affect its reputation and results of operations.
  • Its may be unable to successfully implement or manage the company growth strategy.
  • The Restated Financial Information provided in this Red Herring Prospectus have been provided by the Peer Reviewed Chartered Accountants who are not the Statutory Auditors of the Company.
  • The industry in which the company operates possess various risks and challenges as provided in the Industry Report titled "Industry Report on Diagnostic Industry in India" dated July 22, 2024, which is exclusively prepared for the purposes of the Offer and issued by D&B and is commissioned and paid for by the Company ("D&B Report").
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Industry Outlook of Invicta Diagnostic IPO

  • Diagnostic services help identify medical conditions and support accurate diagnosis, treatment planning, and patient recovery.

  • These services cater to both B2B segments such as hospitals and clinics, and B2C segments involving direct customers.

  • The sector is broadly divided into two key categories: Pathology and Radiology.

  • In India, the Radiology segment recorded a compound annual growth rate (CAGR) of 11.5% between 2020 and 2024.

  • The Indian Radiology market is projected to increase from ₹407 billion in 2024 to ₹868 billion by 2030, reflecting a CAGR of 13.5%, based on available industry estimates.

  • In Maharashtra, the Radiology industry grew at a CAGR of 10.7% during 2020–2024.

  • The market size in the state is estimated to expand from ₹15.04 billion in 2024 to ₹31.4 billion by 2030, supported by a reported CAGR of 13.1%.


Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Invicta Diagnostic IPO.

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amir Chand Jagadish Kumar Exports Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Engineering Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Industries Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO
Bidding Period
20th Feb 2026 - 2nd Feb 2026
Price Range
₹75.0 - 79.0
IPO Size
₹1,65,00,00,000
MANILAM INDUSTRIES INDIA LIMITED IPO
Bidding Period
20th Feb 2026 - 2nd Feb 2026
Price Range
₹65.0 - 69.0
IPO Size
₹40,00,00,000
FRACTAL INDUSTRIES LIMITED IPO
Bidding Period
16th Feb 2026 - 2nd Feb 2026
Price Range
₹205.0 - 216.0
IPO Size
₹49,00,00,000
MARUSHIKA TECHNOLOGY LIMITED IPO
Bidding Period
12th Feb 2026 - 2nd Feb 2026
Price Range
₹111.0 - 117.0
IPO Size
₹27,00,00,000
FRACTAL ANALYTICS LIMITED IPO
Bidding Period
9th Feb 2026 - 2nd Feb 2026
Price Range
₹857.0 - 900.0
IPO Size
₹28,34,00,00,000
AYE FINANCE LIMITED IPO
Bidding Period
9th Feb 2026 - 2nd Feb 2026
Price Range
₹122.0 - 129.0
IPO Size
₹10,10,00,00,000
BIOPOL CHEMICALS LIMITED IPO
Bidding Period
6th Feb 2026 - 2nd Feb 2026
Price Range
₹102.0 - 108.0
IPO Size
₹31,00,00,000
PAN HR SOLUTION LIMITED IPO
Bidding Period
6th Feb 2026 - 2nd Feb 2026
Price Range
₹74.0 - 78.0
IPO Size
₹17,00,00,000
NFP SAMPOORNA FOODS LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹52.0 - 55.0
IPO Size
₹25,00,00,000
BRANDMAN RETAIL LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹167.0 - 176.0
IPO Size
₹86,00,00,000
GROVER JEWELLS LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹83.0 - 88.0
IPO Size
₹34,00,00,000
C K K RETAIL MART LIMITED IPO
Bidding Period
30th Jan 2026 - 2nd Feb 2026
Price Range
₹155.0 - 163.0
IPO Size
₹88,00,00,000
ACCRETION NUTRAVEDA LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹122.0 - 129.0
IPO Size
₹25,00,00,000
MSAFE EQUIPMENTS LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹116.0 - 123.0
IPO Size
₹66,00,00,000
KANISHK ALUMINIUM INDIA LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹73.0 - 73.0
IPO Size
₹29,00,00,000
KASTURI METAL COMPOSITE LIMITED IPO
Bidding Period
27th Jan 2026 - 1st Jan 2026
Price Range
₹61.0 - 64.0
IPO Size
₹18,00,00,000
HANNAH JOSEPH HOSPITAL LIMITED IPO
Bidding Period
22nd Jan 2026 - 1st Jan 2026
Price Range
₹67.0 - 70.0
IPO Size
₹42,00,00,000
SHAYONA ENGINEERING LIMITED IPO
Bidding Period
22nd Jan 2026 - 1st Jan 2026
Price Range
₹140.0 - 144.0
IPO Size
₹15,00,00,000
KRM AYURVEDA LIMITED IPO
Bidding Period
21st Jan 2026 - 1st Jan 2026
Price Range
₹128.0 - 135.0
IPO Size
₹77,00,00,000
SHADOWFAX TECHNOLOGIES LIMITED IPO
Bidding Period
20th Jan 2026 - 1st Jan 2026
Price Range
₹118.0 - 124.0
IPO Size
₹19,07,00,00,000
  • All
  • MainBoard
  • SME
FRACTAL INDUSTRIES LIMITED IPO
Issue Prize
216.00
Listing Day Close
217.55(0.93%)
MARUSHIKA TECHNOLOGY LIMITED IPO
Issue Prize
117.00
Listing Day Close
114.00(-2.56%)
FRACTAL ANALYTICS LIMITED IPO
Issue Prize
900.00
Listing Day Close
847.40(-5.89%)
AYE FINANCE LIMITED IPO
Issue Prize
129.00
Listing Day Close
128.90(0.00%)
BIOPOL CHEMICALS LIMITED IPO
Issue Prize
108.00
Listing Day Close
105.50(-1.85%)
PAN HR SOLUTION LIMITED IPO
Issue Prize
78.00
Listing Day Close
78.01(0.00%)
BRANDMAN RETAIL LIMITED IPO
Issue Prize
176.00
Listing Day Close
192.15(9.09%)
GROVER JEWELLS LIMITED IPO
Issue Prize
88.00
Listing Day Close
100.80(14.77%)
C K K RETAIL MART LIMITED IPO
Issue Prize
163.00
Listing Day Close
171.15(4.91%)
ACCRETION NUTRAVEDA LIMITED IPO
Issue Prize
129.00
Listing Day Close
191.20(48.06%)
MSAFE EQUIPMENTS LIMITED IPO
Issue Prize
123.00
Listing Day Close
150.30(21.95%)
KANISHK ALUMINIUM INDIA LIMITED IPO
Issue Prize
73.00
Listing Day Close
55.48(-24.66%)
KASTURI METAL COMPOSITE LIMITED IPO
Issue Prize
64.00
Listing Day Close
63.16(-1.56%)
HANNAH JOSEPH HOSPITAL LIMITED IPO
Issue Prize
70.00
Listing Day Close
68.25(-2.86%)
SHAYONA ENGINEERING LIMITED IPO
Issue Prize
144.00
Listing Day Close
151.00(4.86%)
KRM AYURVEDA LIMITED IPO
Issue Prize
135.00
Listing Day Close
180.70(34.07%)
SHADOWFAX TECHNOLOGIES LIMITED IPO
Issue Prize
124.00
Listing Day Close
109.90(-11.29%)
DIGILOGIC SYSTEMS LIMITED IPO
Issue Prize
104.00
Listing Day Close
79.05(-24.04%)
ARITAS VINYL LIMITED IPO
Issue Prize
47.00
Listing Day Close
44.65(-4.26%)
ARMOUR SECURITY INDIA LIMITED IPO
Issue Prize
57.00
Listing Day Close
43.35(-24.56%)

Frequently Asked Questions

What is Invicta Diagnostic Ltd IPO?

Answer Field

Invicta Diagnostic Ltd IPO is a SME IPO of 33,08,800 equity shares of a face value of ₹10 aggregating up to ₹28.12 Crores. The issue is priced at ₹80 to ₹85 per share. The minimum order quantity is 1600 Shares. The IPO opens on December 01, 2025, and closes on December 03, 2025. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

When Invicta Diagnostic Ltd IPO will open?

Answer Field

The Invicta Diagnostic Ltd IPO opens on December 01, 2025 and closes on December 03, 2025.

What is the lot size of Invicta Diagnostic Ltd?

Answer Field

Invicta Diagnostic Ltd lot size is 1600 shares, and the minimum amount required is ₹2,72,000.

How to apply for Invicta Diagnostic Ltd IPO?

Answer Field

You can apply in Invicta Diagnostic Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Invicta Diagnostic Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Invicta Diagnostic Ltd IPO will be done on December 04, 2025, and the allotted shares will be credited to your demat account by December 05, 2025.

When is Invicta Diagnostic Ltd IPO listing date?

Answer Field

The Invicta Diagnostic Ltd listing date is December 08, 2025.

Who is the registrar of Invicta Diagnostic Ltd IPO?

Answer Field

The registrar of Invicta Diagnostic Ltd IPO is Bigshare Services Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Socradamus Capital Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Invicta Diagnostic Ltd IPO?

Answer Field

The fresh issue size is ₹28.12 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Invicta Diagnostic Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 1600 shares and ₹2,72,000 amount.

How can I approve the UPI mandate request for Invicta Diagnostic Ltd IPO?

Answer Field

To apply for Invicta Diagnostic Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Invicta Diagnostic Ltd?

Answer Field

The price of each Invicta Diagnostic Ltd share will be ranging in between ₹80 to ₹85 per share.

What is the cut-off time for the UPI mandate for Invicta Diagnostic Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, December 03, 2025.

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|